DK237979A - Fremgangsmaade til fremstilling af proteiner - Google Patents

Fremgangsmaade til fremstilling af proteiner

Info

Publication number
DK237979A
DK237979A DK237979A DK237979A DK237979A DK 237979 A DK237979 A DK 237979A DK 237979 A DK237979 A DK 237979A DK 237979 A DK237979 A DK 237979A DK 237979 A DK237979 A DK 237979A
Authority
DK
Denmark
Prior art keywords
proteins
procedure
production
cleaved
gene
Prior art date
Application number
DK237979A
Other languages
English (en)
Inventor
W Gilbert
S A Broome
L J Villa-Komaroff
A A Efstratiadis
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25433372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK237979(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Harvard College filed Critical Harvard College
Publication of DK237979A publication Critical patent/DK237979A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/30—Signal or leader sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK237979A 1978-06-08 1979-06-07 Fremgangsmaade til fremstilling af proteiner DK237979A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/913,533 US4411994A (en) 1978-06-08 1978-06-08 Protein synthesis

Publications (1)

Publication Number Publication Date
DK237979A true DK237979A (da) 1979-12-09

Family

ID=25433372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK237979A DK237979A (da) 1978-06-08 1979-06-07 Fremgangsmaade til fremstilling af proteiner

Country Status (20)

Country Link
US (1) US4411994A (da)
EP (1) EP0006694B2 (da)
JP (2) JPS5519092A (da)
AT (1) ATE5001T1 (da)
AU (1) AU524856B2 (da)
BG (1) BG60444B2 (da)
CA (1) CA1215920A (da)
DD (1) DD148235A5 (da)
DE (1) DE2966291D1 (da)
DK (1) DK237979A (da)
ES (1) ES481362A1 (da)
FI (1) FI791841A7 (da)
GR (1) GR72953B (da)
IE (1) IE48156B1 (da)
IL (1) IL57491A (da)
MX (1) MX6339E (da)
NZ (1) NZ190524A (da)
PT (1) PT69737A (da)
WO (1) WO1980000030A1 (da)
ZA (1) ZA792486B (da)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU527165B2 (en) * 1977-02-08 1983-02-17 Genentech Inc. Method and means for microbial polypeptide expression; synthetic DNA and process therefor
US6297355B1 (en) 1978-12-22 2001-10-02 Biogen, Inc. Polypeptides displaying HBV antigenicity or hbv antigen specificity
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
GR70279B (da) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
US6455275B1 (en) 1980-02-25 2002-09-24 The Trustees Of Columbia University In The City Of New York DNA construct for producing proteinaceous materials in eucaryotic cells
CA1200773A (en) * 1980-02-29 1986-02-18 William J. Rutter Expression linkers
US4711843A (en) * 1980-12-31 1987-12-08 Cetus Corporation Method and vector organism for controlled accumulation of cloned heterologous gene products in Bacillus subtilis
AU545912B2 (en) * 1980-03-10 1985-08-08 Cetus Corporation Cloned heterologous jive products in bacillies
JP2687995B2 (ja) 1980-04-03 1997-12-08 バイオゲン インコーポレイテッド Ｄｎａ配列、組替えｄｎａ分子およびヒト繊維芽細胞インターフェロン様ポリペプチドの製造方法
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
US6610830B1 (en) 1980-07-01 2003-08-26 Hoffman-La Roche Inc. Microbial production of mature human leukocyte interferons
IL63916A0 (en) * 1980-09-25 1981-12-31 Genentech Inc Microbial production of human fibroblast interferon
US4394443A (en) * 1980-12-18 1983-07-19 Yale University Method for cloning genes
FI64813C (fi) * 1980-12-31 1984-01-10 Ilkka Antero Palva Foerfarande foer producering av ett utvalt aeggviteaemne och vid foerfarandet anvaenda rekombinantplasmidvektorer
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
DK582381A (da) * 1981-01-02 1982-07-03 Univ New York Remkombinat plasmid til anvendelse ved bakteriel kloning
US4663285A (en) * 1981-01-06 1987-05-05 The Public Health Laboratory Service Board Chimeric plasmids
ZA824218B (en) * 1981-06-29 1983-04-27 Cetus Corp Plasmid for producing human insulin
JPS5869897A (ja) * 1981-10-20 1983-04-26 Gakuzo Tamura Ｄｎａ遺伝子
EP0078154A3 (en) * 1981-10-28 1985-01-09 The Regents Of The University Of California Plasmids and cells for heterologous expression of metallothioneins and processes for producing and using the metallothionein
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
US4863855A (en) * 1982-05-14 1989-09-05 The Research Foundation Of State University Of New York Novel cloning vehicles for polypeptide expression in microbial hosts
JPS592689A (ja) * 1982-06-04 1984-01-09 Handai Biseibutsubiyou Kenkyukai 強力な遺伝子発現能を有する新規レプリコンの作成法
US4595658A (en) * 1982-09-13 1986-06-17 The Rockefeller University Method for facilitating externalization of proteins synthesized in bacteria
DE3382547D1 (de) * 1983-01-12 1992-05-27 Chiron Corp Sekretorische expression in eukaryoten.
SE8300693L (sv) * 1983-02-09 1984-08-10 Sven Lofdahl Sett att framstella och isolera proteiner och polypeptider samt en hybridvektor for detta
DK138984A (da) * 1983-03-08 1984-09-09 Rikagaku Kenkyusho Plasmid, fremgangsmaade til fremstilling heraf, mikroorganismer indeholdende samme samt fremgangsmaade til dyrkning af mikroorganismen
JPS59162874A (ja) * 1983-03-08 1984-09-13 Rikagaku Kenkyusho 微生物の培養方法
US4962055A (en) * 1983-03-08 1990-10-09 Rikagaku Kenkyusho Plasmid, method for construction of the same, microorganisms carrying the plasmid and method for cultivation of the microorganism
US4711844A (en) * 1983-03-09 1987-12-08 Cetus Corporation Modified signal peptides
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
WO1984004330A1 (en) * 1983-04-22 1984-11-08 Amgen Secretion of exogenous polypeptides from yeast
EP0561137B1 (en) * 1983-04-25 2002-07-03 Chiron Corporation Hybrid DNA Synthesis of Mature Insulin-like Growth Factors
US7198919B1 (en) 1983-04-25 2007-04-03 Genentech, Inc. Use of alpha factor sequences in yeast expression systems
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
IL71991A (en) 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
FR2549855B1 (fr) * 1983-07-29 1987-03-27 Grp Genie Genetique Sequence nucleotidique codant pour le peptide signal de la toxine diphterique, vecteur contenant cette sequence nucleotidique, leur application a la transformation de micro-organismes et compositions peptidiques obtenues
JPH0646946B2 (ja) * 1984-03-30 1994-06-22 三菱化成株式会社 蛋白の産生方法
US4695542A (en) 1983-10-04 1987-09-22 Dnax Research Institute Of Molecular And Cellular Biology, Inc. cDNA clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
PH23920A (en) * 1983-12-20 1990-01-23 Cetus Corp Glucoamylase cdna
IT1185503B (it) * 1984-01-11 1987-11-12 Univ New York Cloni di odna di eritropietina umana
US4859465A (en) * 1984-04-20 1989-08-22 The Regents Of The University Of California Vaccine capable of eliciting multivalent antibodies
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US5668255A (en) * 1984-06-07 1997-09-16 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US6022950A (en) * 1984-06-07 2000-02-08 Seragen, Inc. Hybrid molecules having translocation region and cell-binding region
US4801537A (en) * 1984-06-08 1989-01-31 Genex Corporation Vector for expression of polypeptides in bacilli
US5672347A (en) * 1984-07-05 1997-09-30 Genentech, Inc. Tumor necrosis factor antagonists and their use
JPH062074B2 (ja) * 1984-07-27 1994-01-12 國男 山根 オリゴペプチドの製法
EP0170266B1 (en) * 1984-07-30 1993-03-24 Wakunaga Seiyaku Kabushiki Kaisha Process for producing protein, and vector, recombinant dna and transformant used therefor
JP2524693B2 (ja) * 1984-07-30 1996-08-14 湧永製薬株式会社 蛋白質の製造法
JP2524695B2 (ja) * 1984-12-26 1996-08-14 湧永製薬株式会社 蛋白質の製造法
US5691181A (en) * 1984-08-21 1997-11-25 Celltech Limited DNA encoding lipase from human gastric mucosal tissue
JPS61268183A (ja) * 1985-05-24 1986-11-27 Wakamoto Pharmaceut Co Ltd Ｄｎａ，組換体ｄｎａおよびそれらを含む微生物
US5272254A (en) * 1984-10-02 1993-12-21 Biogen Inc. Production of streptavidin-like polypeptides
JP2624470B2 (ja) * 1984-10-02 1997-06-25 バイオジェン インコーポレイテッド ストレプトアビジン様ポリペプチドの製造
US4963495A (en) * 1984-10-05 1990-10-16 Genentech, Inc. Secretion of heterologous proteins
US5190874A (en) * 1984-12-28 1993-03-02 Rikagaku Kenkyusho Method for producing penicillinase and xylanase
JPH0817702B2 (ja) * 1984-12-28 1996-02-28 理化学研究所 新規プラスミド及びその調製方法並びにそのプラスミドを含有する新規微生物
US4774180A (en) * 1986-02-26 1988-09-27 Massachusetts Institute Of Technology Construction and application of polyproteins
JP2500311B2 (ja) * 1985-03-19 1996-05-29 工業技術院長 蛋白製造法
JP2620852B2 (ja) * 1985-07-30 1997-06-18 理化学研究所 新規プラスミド及びそれにより形質転換された新規微生物
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
USH2055H1 (en) 1985-09-20 2002-12-03 Zymogenetics, Inc. Expression of tissue-type plasminogen activator in bacteria
EP0240550A4 (en) * 1985-09-26 1989-09-19 Genetics Inst TENSIO-ACTIVE PULMONARY PROTEINS.
AU6408586A (en) * 1985-10-03 1987-04-24 Biotechnology Research Partners Limited Novel lipoprotein-based drug-delivery systems
GB8529014D0 (en) * 1985-11-25 1986-01-02 Biogen Nv Enhanced secretion of heterologous proteins
JPH0669377B2 (ja) * 1985-11-25 1994-09-07 工業技術院長 Ｄｎａ塩基配列およびベクタ−
CA1339757C (en) * 1987-04-16 1998-03-17 Robert F. Halenbeck Production of purified biologically active, bacterially produced recombinant human csf-1
US4929700A (en) * 1987-04-16 1990-05-29 Cetus Corporation Production of purified, biologically active, bacterially produced recombinant human CSF-1
US5084384A (en) * 1987-04-23 1992-01-28 Monsanto Company Secretion of insulin-like growth factor-I
US5426036A (en) * 1987-05-05 1995-06-20 Hoechst Aktiengesellschaft Processes for the preparation of foreign proteins in streptomycetes
US5066792A (en) * 1987-09-04 1991-11-19 Board Of Regents University Of Texas Gene probe for detection of specific human leukemias
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
WO1990002762A1 (en) 1988-09-02 1990-03-22 The Rockefeller University Macrophage-derived inflammatory mediator (mip-2)
FR2648713B1 (fr) * 1989-06-26 1994-06-10 Commissariat Energie Atomique Proteines hybrides entre une enzyme extracytoplasmique et une autre proteine, leur procede de preparation, ainsi que leur application comme agent de diagnostic
US7413537B2 (en) * 1989-09-01 2008-08-19 Dyax Corp. Directed evolution of disulfide-bonded micro-proteins
US5578464A (en) * 1989-10-31 1996-11-26 Schering Corporation E. coli secretory strains
US5595900A (en) * 1990-02-14 1997-01-21 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
WO1992006191A1 (en) * 1990-09-28 1992-04-16 Protein Engineering Corporation Proteinaceous anti-dental plaque agents
DK1820858T3 (da) * 1991-03-01 2009-11-02 Dyax Corp Kimært protein omfatende mikroprotein med to eller flere disulfidbindinger og udförelsesformer deraf
DE69435280D1 (de) 1993-03-10 2010-04-15 Glaxosmithkline Llc Phosphodiesterase des menschlichen Gehirns und Screening-Verfahren
US5691180A (en) * 1994-06-09 1997-11-25 The Regents Of The University Of Michigan DNA sequence encoding N-acetyl-galactosamine-transferase
US5807732A (en) * 1995-02-28 1998-09-15 Lowe; John B. GDP-L-fucose: β-D-galactoside 2-α-L-fucosyltransferases, DNA sequences encoding the same, method for producing the same and a method of genotyping a person
US5770420A (en) * 1995-09-08 1998-06-23 The Regents Of The University Of Michigan Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
US6087128A (en) * 1998-02-12 2000-07-11 Ndsu Research Foundation DNA encoding an avian E. coli iss
US7858339B1 (en) 1998-10-28 2010-12-28 Genentech, Inc. Process for bacterial production of polypeptides
WO2004097001A2 (en) * 2003-04-29 2004-11-11 Genencor International, Inc. Novel bacillus 029cel cellulase
DK1618182T3 (da) 2003-04-30 2013-10-14 Genencor Int Ny bacillus-cellulase MHKcel
EP1618188A4 (en) * 2003-04-30 2008-08-20 Genencor Int NEW BAGCEL CELLULASE FROM BACILLE
WO2004101759A2 (en) * 2003-05-12 2004-11-25 Genencor International, Inc. Novel lipolytic enzyme lip2
US7511005B2 (en) * 2003-05-12 2009-03-31 Danisco Us Inc., Genencor Division Lipolytic enzyme elip
WO2004101763A2 (en) 2003-05-12 2004-11-25 Genencor International, Inc. Novel lipolytic enzyme lip1
US9567381B2 (en) 2012-03-09 2017-02-14 Vestaron Corporation Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides
MX2022013185A (es) 2020-04-20 2022-11-14 Vestaron Corp Polipeptidos variantes proteoliticamente estables de u1-agatoxina-ta1b para el control de plagas.
AU2021265277A1 (en) 2020-05-01 2022-12-08 Vestaron Corporation Insecticidal combinations
AU2021350195A1 (en) 2020-09-28 2023-05-04 Vestaron Corporation Mu-diguetoxin-dc1a variant polypeptides for pest control
EP4314025A2 (en) 2021-04-01 2024-02-07 Vestaron Corporation Av3 mutant polypeptides for pest control
EP4312536A1 (en) 2021-04-01 2024-02-07 Vestaron Corporation Liposome formulations for pesticide delivery and methods for producing and using the same
MX2024006550A (es) 2021-11-29 2024-06-12 Ironwood Pharmaceuticals Inc Composiciones farmaceuticas para el tratamiento del dolor visceral.
EP4499673A1 (en) 2022-03-30 2025-02-05 Vestaron Corporation Combinations of av3 mutant polypeptides and bt toxins for pest control
PY2336430A (es) 2022-05-18 2023-11-27 Vestaron Corp Variantes de péptidos pesticidas actx
WO2023245169A1 (en) 2022-06-17 2023-12-21 Vestaron Corporation Antimicrobial peptide combinations
WO2023245100A1 (en) 2022-06-17 2023-12-21 Vestaron Corporation Antimicrobial ncr13 variant peptides
WO2023245128A1 (en) 2022-06-17 2023-12-21 Vestaron Corporation Antimicrobial peptide
US20260042807A1 (en) 2022-07-29 2026-02-12 Vestaron Corporation Next generation actx peptides
WO2024259306A2 (en) 2023-06-16 2024-12-19 Vestaron Corporation Pvd1 variant polypeptides for pest control
WO2025034576A1 (en) 2023-08-04 2025-02-13 Vestaron Corporation Delta-amaurobitoxin pl1c variant polypeptides for pest control
WO2025226701A1 (en) 2024-04-23 2025-10-30 Vestaron Corporation Proteolytically stable u1-agatoxin-ta1b variant polypeptides for pest control
WO2026050206A1 (en) 2024-08-27 2026-03-05 Ironwood Pharmaceuticals, Inc. Combinations of glp-1 and guanylate cyclase c (gc-c) receptor agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521032A (en) 1974-08-08 1978-08-09 Ici Ltd Biological treatment
US4082613A (en) * 1976-04-23 1978-04-04 The Regents Of The University Of Minnesota Process for the production of insulin by genetically transformed fungal cells
US4190495A (en) 1976-09-27 1980-02-26 Research Corporation Modified microorganisms and method of preparing and using same
JPS53137215A (en) * 1977-05-06 1978-11-30 Harima Refractories Co Ltd Reparing material of blast oven gate by spray method
DK173092B1 (da) * 1977-11-08 2000-01-10 Genentech Inc Rekombinant plasmid, fremgangsmåde til fremstilling af plasmidet, bakterie indeholdende plasmidet, samt fremgangsmåde til f
SE7811458L (sv) * 1977-11-08 1979-05-09 Genentech Inc Forfarande och medel for polypeptidbildning via mikrober
GR71912B (da) 1978-08-11 1983-08-16 Univ California
GB2033905B (en) 1978-08-21 1982-10-13 Upjohn Co Bacterial preparation of proteins

Also Published As

Publication number Publication date
ATE5001T1 (de) 1983-10-15
EP0006694A3 (en) 1980-01-23
JPS5519092A (en) 1980-02-09
US4411994A (en) 1983-10-25
JPS6246160B2 (da) 1987-09-30
NZ190524A (en) 1982-09-14
IL57491A (en) 1983-09-30
EP0006694B2 (en) 1992-01-22
JPH0755151B2 (ja) 1995-06-14
JPS61227598A (ja) 1986-10-09
FI791841A7 (fi) 1981-01-01
IE791115L (en) 1979-12-08
ES481362A1 (es) 1980-03-01
DE2966291D1 (en) 1983-11-17
CA1215920A (en) 1986-12-30
IL57491A0 (en) 1979-10-31
ZA792486B (en) 1981-01-28
EP0006694B1 (en) 1983-10-12
IE48156B1 (en) 1984-10-17
AU524856B2 (en) 1982-10-07
BG60444B2 (bg) 1995-03-31
MX6339E (es) 1985-04-23
WO1980000030A1 (en) 1980-01-10
GR72953B (da) 1984-01-18
EP0006694A2 (en) 1980-01-09
DD148235A5 (de) 1981-05-13
AU4775279A (en) 1979-12-13
PT69737A (en) 1979-07-01

Similar Documents

Publication Publication Date Title
DK237979A (da) Fremgangsmaade til fremstilling af proteiner
ES8202589A1 (es) Metodo para sintetizar dentro de un hospedador bacteriano,y secretar a traves de la membrana del hospedador,una proteinao polipeptido
ATE192500T1 (de) Rekombinante viren vektoren zur expression in muskelzellen
SE8107812L (sv) Rekombinerade dna-molekyler och forfaranden for framstellning av proteiner
ES2046177T3 (es) Construccion de una proteina enlazante a igg para facilitar el tratamiento aguas abajo utilizando ingenieria de proteinas.
ES8306797A1 (es) Un metodo para producir un polipeptido.
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
DE3684892D1 (de) Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens.
BR7908410A (pt) Meio para deteccao de anticorpos de vhb no soro do sangue,e processo para deteccao da presenca da infeccao por virus da hepatite b em seres humanos
YU45871B (sh) Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
ES474849A1 (es) Mejoras en un proceso para la produccion de un producto que comprende un polipeptido especifico
ATE184052T1 (de) Gdf-1 und uog1 proteine
BR8301918A (pt) Proteina,sequencia de dna,veiculo de expressao replicavel,microorganismo ou cultura celular,plasmideo,composicao,cultura de celulas,utilizacao de tal proteina,processo de expressao,processo para producao de um veiculo de expressao e processo para preparacao de uma proteina uroquinase
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
ES2060580T3 (es) Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
JPS6420095A (en) Polypeptide having anti-blood coagulating action
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
KR870004139A (ko) 인체 λ-인터페론의 생물학적 활성 유도체를 제조하는 방법
KR880014107A (ko) 안지오게닌의 유전공학적 제조방법
ATE43139T1 (de) Klonierungs- und expressionsvektoren fuer gammainterferon, transformierte bakterien und verfahren zur herstellung von gamma-interferon.
DK551786D0 (da) Rekombinant-dna-sekvens, der koder for aminosyresekvenser i et toksin, expressionssystem omfattende samme og vaertsceller transformeret hermed
ES2059340T3 (es) Un metodo de preparacion de proteinas.
EP0688224A4 (en) MUTANT PROTEIN, METHODS AND MATERIALS USED FOR ITS MANUFACTURE AND USE
PT742829E (pt) Expressao de proteinas heterologas em bacterias atenuadas utilizando os promotores htra

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment